Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 1
1958 1
1975 1
1977 1
1978 4
1979 5
1980 1
1981 1
1982 1
1983 1
1984 5
1985 2
1986 2
1988 1
1989 4
1991 4
1992 1
1993 1
1994 3
1995 2
1996 4
1997 6
1998 5
1999 6
2000 14
2001 7
2002 10
2003 7
2004 7
2005 12
2006 11
2007 13
2008 14
2009 23
2010 23
2011 16
2012 22
2013 21
2014 25
2015 20
2016 16
2017 25
2018 20
2019 31
2020 50
2021 38
2022 39
2023 29
2024 43
2025 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

570 results

Results by year

Filters applied: . Clear all
Page 1
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.
Fung VSC, Aldred J, Arroyo MP, Bergquist F, Boon AJW, Bouchard M, Bray S, Dhanani S, Facheris MF, Fisseha N, Freire-Alvarez E, Hauser RA, Jeong A, Jia J, Kukreja P, Soileau MJ, Spiegel AM, Talapala S, Tarakad A, Urrea-Mendoza E, Zamudio J, Pahwa R. Fung VSC, et al. Among authors: bray s. Clin Park Relat Disord. 2024 Feb 10;10:100239. doi: 10.1016/j.prdoa.2024.100239. eCollection 2024. Clin Park Relat Disord. 2024. PMID: 38419617 Free PMC article. Review.
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study.
Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, Banach M, De Servi S, Gaita D, Gouni-Berthold I, Hovingh GK, Jozwiak JJ, Jukema JW, Kiss RG, Kownator S, Iversen HK, Maher V, Masana L, Parkhomenko A, Peeters A, Clifford P, Raslova K, Siostrzonek P, Romeo S, Tousoulis D, Vlachopoulos C, Vrablik M, Catapano AL, Poulter NR; DA VINCI study. Ray KK, et al. Among authors: bray s. Eur J Prev Cardiol. 2021 Sep 20;28(11):1279-1289. doi: 10.1093/eurjpc/zwaa047. Eur J Prev Cardiol. 2021. PMID: 33580789
Notch after cleavage.
Bray SJ, Gomez-Lamarca M. Bray SJ, et al. Curr Opin Cell Biol. 2018 Apr;51:103-109. doi: 10.1016/j.ceb.2017.12.008. Epub 2017 Dec 28. Curr Opin Cell Biol. 2018. PMID: 29289895 Review.
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.
McClung MR, Brown JP, Diez-Perez A, Resch H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG, Zanchetta JR, Maddox J, Bray S, Grauer A. McClung MR, et al. Among authors: bray s. J Bone Miner Res. 2018 Aug;33(8):1397-1406. doi: 10.1002/jbmr.3452. Epub 2018 May 22. J Bone Miner Res. 2018. PMID: 29694685 Free article. Clinical Trial.
Decoding the Notch signal.
Falo-Sanjuan J, Bray SJ. Falo-Sanjuan J, et al. Among authors: bray sj. Dev Growth Differ. 2020 Jan;62(1):4-14. doi: 10.1111/dgd.12644. Epub 2019 Dec 30. Dev Growth Differ. 2020. PMID: 31886523 Review.
A new Editor-in-Chief for Development.
Bray S, Storey K, Brown K. Bray S, et al. Development. 2018 Mar 27;145(6):dev165266. doi: 10.1242/dev.165266. Development. 2018. PMID: 29588291 No abstract available.
Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.
Geetha D, Pagnoux C, Sattui SE, Merkel PA, Weiner M, Draibe J, Faguer S, Bray S, Gurlin RE, Balcells-Oliver M, Bruchfeld A, Jayne DR; ADVOCATE Study Group. Geetha D, et al. Among authors: bray s. Rheumatology (Oxford). 2025 Jun 1;64(6):3863-3871. doi: 10.1093/rheumatology/keaf122. Rheumatology (Oxford). 2025. PMID: 40037556 Free PMC article. Clinical Trial.
570 results